SCHEMBL6698577

SCHEMBL6698577

CCCCCc1[c]c2ccccc2cc1CCCCC

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 4/20 0.49
LIPG Q9Y5X9 1/20 0.41
MAPT P10636 2/20 0.37
KCNH2 Q12809 1/20 0.37
ALOX5 P09917 2/20 0.37
MEN1 O00255 1/20 0.37
TP53 P04637 1/20 0.37
CYP3A4 P08684 1/20 0.37
TYR P14679 1/20 0.37
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
KMT2A Q03164 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
GPR3 P46089 1/20 0.35
NR1H2 P55055 1/20 0.35
NR1H3 Q13133 1/20 0.35
PTGS2 P35354 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL158196 0.98 TLR8 (0.48) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL560035 0.98 TLR8 (0.48) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL20694916 0.98 TLR8 (0.48) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL9065394 0.98 TLR8 (0.48) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL3403921 0.98 TLR8 (0.48) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL5500478 0.97 TLR8 (0.47) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL2200831 0.95 TLR8 (0.47) TLR8LIPGMAPTALOX5MEN1
SCHEMBL20694980 0.87 TLR8 (0.47) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL20694968 0.86 TLR8 (0.46) TLR8LIPGMAPTKCNH2ALOX5
SCHEMBL17868740 0.85 TLR8 (0.40) TLR8LIPGMAPTKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945451-B1 Photochrome diaryl-naphtopyran with at least one aminosubstituted aryl rest RODENSTOCK OPTIK G (DE) 2002-12-18 EP claimed
US-20220069354-A1 SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2022-03-03 US disclosed
EP-3904337-A1 SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL FUJIFILM Wako Pure Chemical Corporation (JP) 2021-11-03 EP disclosed
EP-3439097-B1 ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS FUJIFILM WAKO PURE CHEMICAL CORP (JP) 2020-12-30 EP disclosed
US-10727534-B2 Electrolyte solution containing magnesium ions FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2020-07-28 US disclosed
WO-2020138377-A1 SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL 富士フイルム和光純薬株式会社 2020-07-02 WO disclosed
US-20190131657-A1 ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-05-02 US disclosed
EP-3439097-A1 ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS FUJIFILM Wako Pure Chemical Corporation (JP) 2019-02-06 EP disclosed
US-20040197484-A1 Coating liquid for forming insulating film and method for producing insulating film SUMITOMO CHEMICAL COMPANY, LIMITED 2004-10-07 US disclosed
US-4252958-A ACETONE COMPOUND, AMMONIA DONER, HYDRAZINE HYDROHALIDE CATALYST ARGUS CHEMICAL CORPORATION (US) 1981-02-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10727534-B2 Electrolyte solution containing magnesium ions MLX, PRDX1, PRDX6 TLR8 2468/4885LIPG 512/4885MAPT 3696/4885
US-20220069354-A1 SULFUR-BASED ELECTROLYTE SOLUTION FOR MAGNESIUM CELL SLC26A3, PRDX4, PRDX2 TLR8 4273/4885LIPG 3646/4885MAPT 4755/4885
US-20190131657-A1 ELECTROLYTE SOLUTION CONTAINING MAGNESIUM IONS MLX, PRDX1, PRDX6 TLR8 2468/4885LIPG 512/4885MAPT 3696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.